Cas:67665-47-8 2,2′-Dibromo-9,9′-spirobi[fluorene] manufacturer & supplier

We serve Chemical Name:2,2′-Dibromo-9,9′-spirobi[fluorene] CAS:67665-47-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,2'-Dibromo-9,9'-spirobi[fluorene]

Chemical Name:2,2′-Dibromo-9,9′-spirobi[fluorene]
CAS.NO:67665-47-8
Synonyms:L B656 HXJ EE H-& HL B656 HXJ EE;2,2′-Dibromo-9,9′-spirobi[fluorene];2,2′-Dibromo-9,9′-spirobi-(9H-fluorene);9,9′-Spirobi[9H-fluorene], 2,2′-dibromo-;2,2′-DIBROMO-9,9′-SPIROBIFLUORENE;2,2’-Dibromo-9,9’-spiroBi[9H-fluorene]
Molecular Formula:C25H14Br2
Molecular Weight:474.187
HS Code:2903999090

Physical and Chemical Properties:
Melting point:240°C(lit.)
Boiling point:557.4±50.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.804
PSA:
Exact Mass:471.946198
LogP:8.04

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like L B656 HXJ EE H-&amp chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,2’-Dibromo-9,9’-spiroBi[9H-fluorene] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9,9′-Spirobi[9H-fluorene], 2,2′-dibromo- Use and application,9,9′-Spirobi[9H-fluorene], 2,2′-dibromo- technical grade,usp/ep/jp grade.


Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry. 2,2′-Dibromo-9,9′-spirobi[fluorene] manufacturer The two trials studied similar patient populations, Tendler said, but VMP was an old standard of care that’s not really used today in the U.S. Still, Tendler believes the two regimens may both have roles to play based on each patient’s ability to tolerate them. Whichever cocktail physicians choose, the two phase 3 studies have confirmed the benefit of Darzalex in transplant-ineligible patients, he added. 2,2′-Dibromo-9,9′-spirobi[fluorene] supplier AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. 2,2′-Dibromo-9,9′-spirobi[fluorene] vendor The two trials studied similar patient populations, Tendler said, but VMP was an old standard of care that’s not really used today in the U.S. Still, Tendler believes the two regimens may both have roles to play based on each patient’s ability to tolerate them. Whichever cocktail physicians choose, the two phase 3 studies have confirmed the benefit of Darzalex in transplant-ineligible patients, he added. 2,2′-Dibromo-9,9′-spirobi[fluorene] factory Pharmaceutical intermediates and APIs belong to the fine chemical industry.